Lattice Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Lattice Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,200	Closed	-$226K	–	41
2023 Q2	$226K	Hold	9,200	–	–	0.03%	34
2023 Q1	$374K	Hold	9,200	–	–	0.05%	39
2022 Q4	$414K	Hold	9,200	–	–	0.07%	34
2022 Q3	$440K	Hold	9,200	–	–	0.7%	32
2022 Q2	$501K	Hold	9,200	–	–	0.06%	32
2022 Q1	$1.06M	Hold	9,200	–	–	1.51%	20
2021 Q4	$1.39M	Buy	+9,200	New	+$1.24M	0.1%	20

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lattice Capital Management's TNDM Position: Q3 2023 in Review

Lattice Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 9,200 shares — an estimated $226K sold.

Lattice Capital Management first reported a position in TNDM in Q4 2021 and held it in 7 quarters. The position peaked at $1.39M in Q4 2021. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

Lattice Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
Lattice Capital Management sold 9,200 Tandem Diabetes Care shares in Q3 2023, an estimated $226K.
Lattice Capital Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 7 quarters.
Lattice Capital Management's Tandem Diabetes Care position peaked at $1.39M in Q4 2021.
226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Lattice Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.